Wolf and Dr. Rubinek team at Tel Aviv University and Sourasky Medical Center REHOVOT, Israel, April 16, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ ...

About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance.

REHOVOT, Israel - Purple Biotech Ltd. (NASDAQ/TASE: PPBT), a clinical-stage biopharmaceutical company with a market capitalization of $6.07 million, today announced the appointment of Shai Lankry ...

Rossari Biotech Limited was founded in 2003 as a ... Rossari Personal Care Products Private Limited (Formerly known as Neutron Impex Private Limited) which was engaged in the business of ...

(RTTNews) - Purple Biotech Ltd. (PPBT, PPBT.TA), an Israeli clinical-stage biotechnology company, on Monday announced that it has appointed Shai Lankry as its Chief Financial Officer. Lankry has ...

Ajooni Biotech Limited was originally incorporated as a Private Limited Company with the name Ajooni Biotech Private Limited at Chandigarh on 17th February, 2010. Consequent upon conversion of the ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

View today's HOB Biotech Group Corp Ltd stock price and latest 688656 news and analysis. Create real-time notifications to follow any changes in the live stock price.

Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a $130 million series B fundraising round. The round was led by Kleiner Perkins ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Purple Biotech Ltd. has appointed Shai Lankry as its new Chief Financial Officer, bringing over 20 years of experience in financial leadership within the biotech and healthcare sectors.